They’re two separate things, nothing has changed? Patient enrolment occurs in Q1 (after ethics approval, likely late Feb early March), first dose is Q2 (likely earlier in the quarter, eg April, May ).
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Selects Advanced Clinical as CRO for Phase 3
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
43.0¢

Ann: PAR Selects Advanced Clinical as CRO for Phase 3, page-6
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $170.8M |
Open | High | Low | Value | Volume |
43.0¢ | 43.0¢ | 41.5¢ | $141.6K | 337.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9738 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 76716 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9738 | 0.415 |
3 | 46000 | 0.410 |
1 | 1250 | 0.405 |
7 | 114000 | 0.400 |
2 | 33076 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 66716 | 3 |
0.435 | 1447 | 1 |
0.440 | 89875 | 4 |
0.445 | 11400 | 2 |
0.450 | 92730 | 8 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online